Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.

National Cancer Center Korea is a South Korean company located in Goyang-si and ultimately controlled by the Government of South Korea. The firm provides clinical and medical research services.

Shengzhan Biotechnology Co., Ltd. was established in April of the Republic of China. It is an emerging important strategic industry. Its business is based on biotechnology, including microbial fermentation technology, research and development and production of APIs, health food ingredients, animal feed additives. And agricultural biotechnology products. The domestic stock listed company Shengda Chemical Pharmaceutical Co., Ltd. is the parent company of the company holding more than 50% of the shares. The company is a subsidiary of Shengda Company which is vertically integrated, aiming at developing high-tech and high value-added products. Reduce costs and benefit more people.

Korea Food Research Institute is a global food R&D institution that contributes to the health of Korea.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

The Institut national de la recherche agronomique (INRA, pronounced [inʁa]; English: National Institute of Agricultural Research) is a French public research institute dedicated to agricultural science. It was founded in 1946 and is a Public Scientific and Technical Research Establishment under the joint authority of the Ministries of Research and Agriculture.

FUJIFILM Corp. engages in the provision of imaging and information solutions. Its offers photography equipment, supplies and services, optical devices, healthcare, high-performance materials, graphic systems, recording media, and industrial products. The company was founded on October 2, 2006 and is headquartered in Tokyo, Japan.

Anicom Holdings, Inc. engages in the operation and business management of its group companies. It operates through the Non-life Insurance and Others segments. The Non-life Insurance segment conducts insurance underwriting and asset management for pet insurance. The Others segment includes animal hospital support business, insurance agency business, research and clinical business in the field of animal medicine. The company was founded by Nobuaki Komori on July 5, 2000 and is headquartered in Tokyo, Japan.

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Second Genome’s mission is to transform lives with medicines developed through innovative microbiome science. Second Genome has built a novel platform for microbiome drug discovery. Second Genome has completed more than 400 microbiome studies, analyzing more than 75,000 samples, for internal R&D, as well as for external partners across government, academia, pharmaceutical, nutrition and industrial companies. The team leverages its microbiome analysis platform with its partners’ specific expertise to generate insightful findings that can accelerate research programs by elucidating the role of the microbiome in human health conditions, agriculture, animal health and other industries. The company has established a pipeline of therapeutic products for the treatment of inflammation and metabolic diseases.

Manufactures food ingredients such as sweeteners, food stabilizers and acidulants

White Dog Labs, Inc. is an American private company that develops probiotics for animals and humans.\nThe company says this about itself: WDL is a biotech company focused on animal health and nutrition today – human’s tomorrow. It was established in 2012 to address global challenges including food sustainability and climate change, and is funded by Musea Ventures, the investment arm of the Somekh family. The company has a unique, world class expertise in microbiome derived organisms which have promising implications for nutrition and health. The company has invented a proprietary process, ProtocolB™, for the isolation, selection and cultivation of microbiome-derived organisms, and developed MixoFerm™, a fermentation technology that consumes sugar and gases, thus increasing product yield in industrial fermentation. WDL is applying this expertise to develop and commercialize the \"Tyton\" platform of unique products.

ENDURANCE & MES (Chongqing) Environment Co. Ltd, part of MITSUI E&S Co., Ltd., is a company headquartered in Chongqing, China. The firm provides engineering, construction and shipbuilding services.

Med-Life Discoveries is a biopharmaceutical company that develops synthetic plasmalogens and plasmalogen precursors for the treatment of diseases. They provide metabolic precursor products that contain the chemical bonds that the peroxisomal enzymes normally produce to treat Alzheimer's disease and Parkinson's disease. Their objective is to build on decades of research revealing that metabolic abnormalities occur before the development of disease.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Gusto Global is a biotechnology company that revolutionizes human health by building the discovery and development platform that applies ecological principles to restore key functionalities of a healthy microbiome. The company's platform integrates advanced computational and microbiological tools to discover and develop novel Live Biotherapeutic Products (LBPs) with unprecedented speed and efficiency. Its ecological approach combines proprietary bioinformatics, AI, and microbiology expertise to identify differences in core microbiome functionalities between healthy and unhealthy individuals. Gusto's live biotherapeutics and companion diagnostics offer the potential for safer and more effective patient-centric care through disease prevention, early detection/diagnosis, intervention, and monitoring. Gusto Global was founded in 2015 and is headquartered in Charlotte, North Carolina.

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of functional sugar alcohols and starch sugar products. Its products include xylitol, sorbitol, maltitol, xylose, L-arabinose, and fructose syrup. The company was founded on July 10, 2001 and is headquartered in Quzhou, China.